ACTIVITY OF VARIOUS AMPHIPHILIC AGENTS IN REVERSING MULTIDRUG RESISTANCE OF L-1210 CELLS

被引:24
作者
POMMERENKE, EW
OSSWALD, H
HAHN, EW
VOLM, M
机构
[1] GERMAN CANC RES CTR,INST EXPTL PATHOL,NEUENHEIMER FELD 280,W-6900 HEIDELBERG 1,GERMANY
[2] GERMAN CANC RES CTR,INST TOXICOL & CHEMOTHERAPY,W-6900 HEIDELBERG 1,GERMANY
[3] GERMAN CANC RES CTR,INST RADIOL & PATHOPHYSIOL,W-6900 HEIDELBERG 1,GERMANY
关键词
multidrug-resistance; nucleoside incorporation assay; reversal;
D O I
10.1016/0304-3835(90)90060-B
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several compounds (bamipine, chlorphenoxamine, estracyt, hycanthone, quinidine, quinine, tamoxifen, trifluoperazine and verapamil) have a common basic structure with the following features: lipophilic aromatic ring system; linked chain hydrophilic N-alkyl group. They are used medically for varying diseases. Their activity in reversing multidrug-resistance (MDR) with other compounds (diethylstilbestrol, β-estradiol, methylbiguanide, methylpiperazine, testosterone) lacking one of these chemical features is compared. The in vitro test system we used was the nucleoside incorporation assay using parental L 1210 ascites tumor cells and a doxorubicin resistant subline, which expresses the MDR phenotype. The substances lacking one of these features were not effective in reversing the MDR whereas all other tested substances demonstrated modulating potential in the MDR resistant L 1210 cells. © 1990.
引用
收藏
页码:17 / 23
页数:7
相关论文
共 27 条
[21]   NON-CHEMOTHERAPEUTIC AGENTS THAT POTENTIATE CHEMOTHERAPY EFFICACY [J].
STEWART, DJ ;
EVANS, WK .
CANCER TREATMENT REVIEWS, 1989, 16 (01) :1-40
[22]   MECHANISMS OF MULTIDRUG RESISTANCE AND IMPLICATIONS FOR THERAPY [J].
TSURUO, T .
JAPANESE JOURNAL OF CANCER RESEARCH, 1988, 79 (03) :285-296
[23]   DETECTION OF INDUCED RESISTANCE TO CYTOSINE-ARABINOSIDE WITH A SHORT-TERM TEST [J].
VOLM, M ;
MAAS, E ;
MATTERN, J .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (05) :733-736
[24]   INDUCED MULTIDRUG RESISTANCE IN MURINE LEUKEMIA-L1210 AND ASSOCIATED CHANGES IN A SURFACE-MEMBRANE GLYCOPROTEIN [J].
VOLM, M ;
BAK, M ;
EFFERTH, T ;
MATTERN, J .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1989, 115 (01) :17-24
[25]  
VOLM M, 1987, ARZNEIMITTEL-FORSCH, V37-2, P862
[26]   PRE-THERAPEUTIC DETECTION OF TUMOR RESISTANCE AND THE RESULTS OF TUMOR-CHEMOTHERAPY [J].
VOLM, M ;
WAYSS, K ;
KAUFMANN, M ;
MATTERN, J .
EUROPEAN JOURNAL OF CANCER, 1979, 15 (07) :983-993
[27]  
ZAMORA JM, 1988, MOL PHARMACOL, V33, P454